Compass Therapeutics, Inc. (CMPX)
NASDAQ: CMPX · Real-Time Price · USD
5.65
-0.13 (-2.25%)
At close: Feb 27, 2026, 4:00 PM EST
5.76
+0.11 (1.95%)
After-hours: Feb 27, 2026, 7:51 PM EST
Compass Therapeutics Market Cap
Compass Therapeutics has a market cap or net worth of $1 billion as of February 27, 2026. Its market cap has increased by 100.10% in one year.
Market Cap
1.00B
Enterprise Value
794.89M
1-Year Change
100.10%
Ranking
Category
Stock Price
$5.65
Market Cap Chart
Since April 5, 2021, Compass Therapeutics's market cap has increased from $435.34M to $1.00B, an increase of 130.84%. That is a compound annual growth rate of 18.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 26, 2026 | 1.03B | 7.64% |
| Dec 31, 2025 | 955.12M | 378.75% |
| Dec 31, 2024 | 199.50M | 0.34% |
| Dec 29, 2023 | 198.83M | -68.61% |
| Dec 30, 2022 | 633.47M | 105.02% |
| Dec 31, 2021 | 308.98M | -29.02% |
| Apr 5, 2021 | 435.34M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Geron | 1.07B |
| Bicara Therapeutics | 1.06B |
| Aktis Oncology | 1.04B |
| AbCellera Biologics | 1.04B |
| Xeris Biopharma Holdings | 1.01B |
| Ventyx Biosciences | 1.00B |
| uniQure | 999.16M |
| Phathom Pharmaceuticals | 999.04M |